Posts

Posted on

Collaborative Science Supplement Requests Due in January

by
0 comments

Do you have an idea for a great collaboration that will advance your NIGMS-funded research project? If your current award has active funding through at least July 31, 2012, you may be eligible to jump-start your idea with an administrative supplement for collaborative science. The next submission deadline is January 15, 2011.

To be sure that your project is appropriate for this program, please review the funding opportunity announcement. You should also discuss the project idea with your NIGMS program director before preparing an application. For general questions about the program, contact me at hayness@nigms.nih.gov or Marion Zatz at zatzm@nigms.nih.gov.

Posted on

New Funding Opportunity for Stem Cell Researchers

by
0 comments

NIGMS has just issued a call for Program Projects for Collaborative Research on the Basic Biology of Pluripotency and Reprogramming (P01), with an emphasis on human induced pluripotent stem (iPS) cells. We are particularly interested in studies that propose comprehensive analyses of the basic biology of pluripotency, the molecular events and mechanisms of reprogramming, and the epigenetics and epigenomics of the pluripotent and reprogrammed states.

These applications have special requirements, so please read the announcement carefully. Letters of intent are due on November 1, and applications are due on December 1.

If your research involves stem cells but isn’t appropriate for this announcement, you may submit an investigator-initiated R01 application that addresses the basic biology of stem cells and/or uses these cells as model systems to study fundamental life processes.

You may contact me at hayness@nigms.nih.gov or Marion Zatz at zatzm@nigms.nih.gov with questions about this new opportunity or about NIGMS support for stem cell research.

Posted on

Scoring Analysis with Funding and Investigator Status

by
17 comments

My previous post generated interest in seeing the results coded to identify new investigators and early stage investigators. Recall that new investigators are defined as individuals who have not previously competed successfully as program director/principal investigator for a substantial NIH independent research award. Early stage investigators are defined as new investigators who are within 10 years of completing the terminal research degree or medical residency (or the equivalent).

Below is a plot for 655 NIGMS R01 applications reviewed during the January 2010 Council round.

A plot of the overall impact score versus the percentile for 655 NIGMS R01 applications reviewed during the January 2010 Council round. Solid symbols show applications for which awards have been made and open symbols show applications for which awards have not been made. Red circles indicate early stage investigators, blue squares indicate new investigators who are not early stage investigators and black diamonds indicate established investigators.

A plot of the overall impact score versus the percentile for 655 NIGMS R01 applications reviewed during the January 2010 Council round. Solid symbols show applications for which awards have been made and open symbols show applications for which awards have not been made. Red circles indicate early stage investigators, blue squares indicate new investigators who are not early stage investigators and black diamonds indicate established investigators.

This plot reveals that many of the awards made for applications with less favorable percentile scores go to early stage and new investigators. This is consistent with recent NIH policies.

The plot also partially reveals the distribution of applications from different classes of applicants. This distribution is more readily seen in the plot below.

A plot of the cumulative fraction of applications for four classes of applications with a pool of 655 NIGMS R01 applications reviewed during the January 2010 Council round. The classes are applications from early stage investigators (red squares), applications from new investigators (blue circles), new (Type 1) applications from established investigators (black diamonds) and competing renewal (Type 2) applications from established investigators (black triangles). N indicates the number in each class of applications within the pool.

A plot of the cumulative fraction of applications for four classes of applications with a pool of 655 NIGMS R01 applications reviewed during the January 2010 Council round. The classes are applications from early stage investigators (red squares), applications from new investigators (blue circles), new (Type 1) applications from established investigators (black diamonds) and competing renewal (Type 2) applications from established investigators (black triangles). N indicates the number in each class of applications within the pool.

This plot shows that competing renewal (Type 2) applications from established investigators represent the largest class in the pool and receive more favorable percentile scores than do applications from other classes of investigators. The plot also shows that applications from early stage investigators have a score distribution that is quite similar to that for established investigators submitting new applications. The curve for new investigators who are not early stage investigators is similar as well, although the new investigator curve is shifted somewhat toward less favorable percentile scores.

Posted on

Apply Now for Microbial Community Dynamics Grants

by
0 comments

NIGMS has just re-announced the Dynamics of Host-Associated Microbial Communities (R01) funding opportunity. Microbes make up the vast majority of our bodies’ cells, and this program supports projects that aim to dissect these complex communities and their roles within a host.

We are particularly interested in applications that propose:

  • Genetic, physiological and ecological research on mixed microbial communities, their internal dynamics and how they relate to those of the host; and
  • Studies on other experimental models that could make breakthrough contributions to understanding the formation and dynamics of host-microbe symbiotic systems.

We encourage interdisciplinary approaches, including bioinformatics/computational/modeling and/or experimental manipulations to investigate host-associated microbial community ecology.

You may apply for up to $250,000 (direct costs) per year (plus up to $100,000 for exceptional equipment in the first year). Most awards will be for 4 years. Letters of intent are due on December 14, 2010, and applications are due on January 14, 2011.

For more details about the program, see the funding opportunity announcement or contact me at 301-594-3900 or singhs@nigms.nih.gov.

Posted on

Update: Status of hESC Applications and Grants

by and
0 comments

NIH has rescinded the earlier notice regarding the status of applications and grants involving human embryonic stem cells. The new notice states that the receipt, processing, review and awarding of NIH applications and proposals involving human embryonic stem cells will continue. It goes on to list the following actions:

  • The suspension of further NIH activity to implement, apply or act pursuant to the NIH Guidelines is hereby lifted.
  • The suspension of the issuance of all pending competing, and noncompeting continuation hESC awards and contracts approved for funding is hereby lifted.
  • The suspension of the peer review of all pending competing hESC applications and proposals is hereby lifted.
  • The NIH Human Embryonic Stem Cell Registry will resume accepting submissions of information about hESC lines for the purpose of establishing eligibility for funding under the NIH Guidelines. The NIH review of hESC lines for inclusion on the Registry under the NIH Guidelines will also resume.
Posted on

Modeling Scientific Workforce Dynamics

by
0 comments

In keeping with the Institute’s long-standing interest in training and its strong commitment to fostering a diverse scientific workforce, we have just re-announced our Modeling the Scientific Workforce (U01) program.

This program provides support for developing computational models of the scientific workforce in the United States. It takes a systems-based approach to understanding the underlying dynamics that produce successful scientists, examining strategies for increasing the diversity of the scientific workforce, identifying research questions and guiding data collection and analysis. The models will help inform our program development, management and evaluation.

We are particularly interested in models of the academic scientific workforce, but applicants should also consider industry and the government. We strongly encourage collaboration among scientists who are experts in simulation modeling, large-scale educational data sets, national policy and program development and other appropriate areas.

Letters of intent are due on October 4, 2010, and applications are due on November 4, 2010.

For additional information about the program, see the funding opportunity announcement or contact me at 301-594-3900 or singhs@nigms.nih.gov.

Posted on

Status of hESC Applications and Grants

by and
0 comments

NIH has issued a notice describing the status of applications and grants that propose research using human embryonic stem cells (hESC). Among its points are:

  • Any further NIH activity to implement, apply or act pursuant to the NIH Guidelines is hereby suspended until further notice.
  • Issuance of all pending competing, and noncompeting continuation hESC awards and contracts is suspended until further notice.
  • The peer review of all pending competing hESC applications and proposals is suspended until further notice.

Grants affected include all types of research and training. We expect more guidance soon and will let you know when it’s posted.

Posted on

Scoring Analysis with Funding Status

by
15 comments

In response to a previous post, a reader requested a plot showing impact score versus percentile for applications for which funding decisions have been made. Below is a plot for 655 NIGMS R01 applications reviewed during the January 2010 Council round.

A plot of the overall impact score versus the percentile for 655 NIGMS R01 applications reviewed during the January 2010 Council round. Green circles show applications for which awards have been made. Black squares show applications for which awards have not been made.

A plot of the overall impact score versus the percentile for 655 NIGMS R01 applications reviewed during the January 2010 Council round. Green circles show applications for which awards have been made. Black squares show applications for which awards have not been made.

This plot confirms that the percentile representing the halfway point of the funding curve is slightly above the 20th percentile, as expected from previously posted data.

Notice that there is a small number of applications with percentile scores better than the 20th percentile for which awards have not been made. Most of these correspond to new (Type 1, not competing renewal) applications that are subject to the NIGMS Council’s funding decision guidelines for well-funded laboratories.

Posted on

New Distributor for Knockout Mice

by
0 comments

MouseNIGMS (and other NIH) investigators previously have been able to obtain over 2,500 knockout mouse strains at a negotiated cost from Lexicon. These mouse strains are no longer available directly through Lexicon.

You may now request them, along with an additional 1,000 knockout strains, through Taconic. NIH investigators acquiring a Lexicon knockout mouse through Taconic are expected to place the mouse lines in a NIH-supported mouse repository.

The NIH Guide notice updates the policy and provides more details.

Posted on

New NIH Principal Deputy Director

by
1 comment

Dr. Lawrence A. TabakNIH Director Francis Collins recently named Larry Tabak as the NIH principal deputy director. Raynard Kington previously held this key position.

Over the years, I have worked closely with Dr. Tabak in many settings, including the Enhancing Peer Review initiative. A biochemist who continues to do research in the field of glycobiology, he is a firm supporter of investigator-initiated research and basic science. He is also a good listener and a creative problem solver.

Dr. Tabak, who has both D.D.S. and Ph.D. degrees, has directed NIH’s National Institute of Dental and Craniofacial Research for the past decade. In 2009, Dr. Kington—who had stepped in as acting director of NIH following the departure of Elias Zerhouni—tapped Dr. Tabak to be his acting deputy. Dr. Tabak’s achievements included playing an integral role in NIH Recovery Act activities.

Given the challenging issues that the principal deputy director often works on, Dr. Tabak’s experience—from dentist and bench scientist to scientific administrator—clearly provides him with valuable tools for the job. His experience as an endodontist may be particularly useful in some situations, allowing him to identify and “treat” potentially serious issues.